Northrop Grumman 2024 sales rise 4% to $41.0 billion; 2025 guidance held
Northrop Grumman reported 2024 sales of $41.0 billion, up 4 percent from $39.3 billion in 2023, and net earnings of $4.2 billion, or $28.34 per diluted share. That figure includes a $332 million after-tax pension mark-to-market benefit; excluding it, MTM-adjusted EPS was $26.08, compared with $15.61 in 2023, which included a B-21 charge. The company said its 2025 financial guidance is in line with its prior outlook.
Key points
- Fourth quarter 2024 sales were $10.7 billion, comparable with the prior-year quarter, and diluted EPS was $8.66.
- 2024 free cash flow was $2.6 billion, up 25 percent, and the company returned $3.7 billion to shareholders through buybacks and dividends.
- 2025 guidance: sales of $42.0 billion to $42.5 billion, MTM-adjusted EPS of $27.85 to $28.25, and free cash flow of $2.85 billion to $3.25 billion.
- Backlog reached a record $91.5 billion; the Training Services divestiture is expected to close mid-year 2025.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 30, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.